Development of a therapeutic genome editing for hyper-IgE syndrome
| Project/Area Number |
15K15392
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Pediatrics
|
|---|
| Research Institution | The University of Tokushima |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2015-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
|
|---|
| Keywords | 免疫学 / ゲノム編集 / 小児科学 / 免疫不全症 / STAT3 |
|---|
| Outline of Final Research Achievements |
Hyper-IgE syndrome is characterized by the extremely high serum IgE levels, severe atopic dermatitis, and recurrent staphylococcal infections to the skin and lung. This disorder is caused by a substitution of a single nucleotide of a single allele of STAT3 gene. To treat this disorder with genome editing, we need to establish a CRISPER/Cas9, which could discriminate a difference of the single nucleotide. To this end, we established a reporter assay, specifically detect double strand break by CRISPER/Cas9. With this model system, we successfully identified a CRISPR/Cas9, which specifically cleave mutant STAT3 allele, but not cleave wild-type STAT3 allele.
|
Report
(2 results)
Research Products
(10 results)
